Clinical trials
Growth clinical trials
Below are recruiting growth clinical trials, each written for real people, not researchers. We’re tracking 295 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06732843Recruiting
Comparing two IVF medications for egg and embryo quality
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
Abu Dhabi, Abu Dhabi EmirateAges 18–38 - NCT06767800RecruitingPhase 2
Study of TQB2102 with immunotherapy for HER2-positive gastroesophageal cancer
This trial tests a new combination of drugs (TQB2102, benmelstobart, and pembrolizumab) with or without chemotherapy for people with HER2-positive gastroesophageal cancer that cannot be removed by surgery or has spread. It aims to see if this combination is more effective than current treatments.
Fuyang, AnhuiAges 18–75 - NCT06760819RecruitingPhase 2
Sevacertinib for solid tumors with HER2 mutations
This study tests an oral tablet called sevacertinib in people with solid tumors (not lung cancer) that have a HER2 mutation. It aims to see how well the drug works and how safe it is for people who have tried other treatments or have no good options left.
Birmingham, AlabamaAges 18 years+ - NCT06756932RecruitingPhase 1
Bcl-2 inhibitor combo for advanced HR+ breast cancer
This trial tests a new Bcl-2 inhibitor (BGB-21447) combined with other therapies for advanced HR+/HER2- breast cancer that has already been treated with hormone therapy and a CDK4/6 inhibitor. It aims to see if these combinations are safe and effective.
Iowa City, IowaAges 18 years+ - NCT06719102Recruiting
Support for mothers and caregivers with new babies
This study looks at how mothers and other caregivers can help their babies grow and thrive. You and your baby would be videotaped during some play and feeding sessions to understand your interactions better.
Austin, TexasAges birth–90 years - NCT06115122Recruiting
PEPPI Study: Finding early signs of placental problems in pregnancy
This study looks at blood markers to find women at risk for placental problems during pregnancy. It involves blood tests in early and late pregnancy, and at birth, to see how iron levels and other factors affect the placenta and baby's health.
OuluAges Any age - NCT06668831Recruiting
FGF23 and heart rhythm in dialysis patients
This study looks at whether a blood protein called FGF23 is linked to irregular heartbeats in people on long-term hemodialysis (kidney dialysis). It may help doctors better predict heart risks.
LuganoAges 18 years+ - NCT06705452Recruiting
MRI study of unruptured brain aneurysm growth
This study uses MRI scans to track how brain aneurysms that haven't bled change over time. It may help doctors understand which aneurysms are most likely to grow.
ReimsAges 18 years+ - NCT06667076RecruitingPhase 2
Amivantamab combinations for advanced EGFR-mutant lung cancer
This trial tests two treatment combinations for people with a specific type of advanced lung cancer that has an EGFR mutation. One group gets amivantamab plus lazertinib, and the other gets amivantamab plus chemotherapy. The goal is to see which combo works better.
Daphne, AlabamaAges 18 years+ - NCT06666127Enrolling by invitation
Muscle force and growth study
This study looks at how the force of your muscle contractions at different lengths affects muscle growth and strength. You will do leg exercises on a special machine to see how your muscles respond.
Vancouver, British ColumbiaAges 19–30 - NCT06652503Recruiting
Student wellness and emotional growth program
This trial tests a program called SWAG-R designed to help NSU undergraduate students build resilience and manage emotions. It may be a good fit if you are not currently in therapy or dealing with serious mental health issues.
Fort Lauderdale, FloridaAges 18 years+ - NCT06633250Recruiting
Testing a rice-based formula for babies with cow's milk allergy
This trial tests a special formula made from hydrolyzed rice protein in babies with cow's milk protein allergy. The goal is to see if the formula supports healthy growth and is well-tolerated, while also improving quality of life.
BerlinAges Up to 8 months - NCT03648814Recruiting
Bevacizumab eye injections for neovascular glaucoma
This study compares two ways of giving the medicine bevacizumab in the eye: into the front part (intracameral) versus deeper inside (intravitreal). It aims to see which approach better controls neovascular glaucoma and helps vision, especially when surgery (trabeculectomy) is needed.
Hat Yai, Changwat SongkhlaAges 18 years+ - NCT06625593RecruitingPhase 1
Study of BG-C137 for advanced solid tumors
This trial tests a new drug called BG-C137 for people with advanced solid tumors that have stopped responding to other treatments. The drug targets a protein called FGFR2b found on some cancer cells, aiming to deliver a therapy directly to the tumor.
Los Angeles, CaliforniaAges 18 years+ - NCT06587035Recruiting
Study of somatrogon for pediatric growth hormone deficiency in India
This study looks at how well somatrogon works for children 3 years and older with growth hormone deficiency. It may help you understand if this treatment is an option for your child.
Bengaluru, KarnatakaAges 3–17 - NCT06594900Enrolling by invitation
Muscle strength in kids before puberty, with training
This study looks at how resistance training affects muscle function in prepubertal children. It compares changes from training to normal growth, and aims to help kids get stronger safely.
Basel, BasellandschaftAges 7–11 - NCT06571500Recruiting
Growth hormone and insulin cells in type 2 diabetes risk
This study looks at how growth hormone affects insulin-making cells in people at risk for type 2 diabetes. It may help explain why some people with a family history of diabetes develop the condition.
Columbia, MissouriAges 18–59 - NCT06571487Recruiting
Growth hormone resistance in beta cells after pregnancy
This study looks at how the body's insulin-making cells (beta cells) might become resistant to growth hormone after a full-term pregnancy. It compares women who had gestational diabetes to those who didn't, to learn more about diabetes risk. You may join if you had a healthy single-baby pregnancy in the last 5 years and never had type 1 or type 2 diabetes.
Columbia, MissouriAges 18–45 - NCT06550986Recruiting
Polymer device to close false lumen in type B dissection
This trial tests a new polymer device to close the false lumen (an extra channel) in the aorta for people with type B aortic dissection. It may prevent the aorta from growing and reduce the risk of complications.
AucklandAges 18 years+ - NCT04235517Recruiting
Study of growth plate behavior after temporary growth plate surgery
This study looks at how a child’s growth plate grows during and after a temporary growth plate procedure. It may help doctors better time and plan treatment for children whose leg alignment or leg length differs.
OsloAges 3–16 - NCT06497959RecruitingPhase 3
Ultrasound study of placenta blood flow
This trial uses a special contrast dye during ultrasound to examine blood flow in the placenta of pregnant women who have chosen to end their pregnancy for medical reasons. It may help understand the role of poor placental blood flow in severe fetal growth restriction.
NancyAges 18–64 - NCT06511648RecruitingPhase 2
Erdafitinib with or without immunotherapy for FGFR-altered bladder cancer
This trial tests a targeted therapy called erdafitinib, either alone or combined with an immunotherapy drug (cetrelimab), for people with muscle-invasive bladder cancer that has a specific FGFR gene change. It may be an option if you cannot take cisplatin chemotherapy and have not had prior treatment for this cancer.
Clermont-FerrandAges 18 years+ - NCT06452277RecruitingPhase 3
Testing sevabertinib for advanced HER2-mutated lung cancer
This trial compares a new targeted drug called sevabertinib against standard chemotherapy plus immunotherapy for people with advanced non-small cell lung cancer that has a specific HER2 gene mutation. The goal is to see if sevabertinib works better and is safe.
Newport Beach, CaliforniaAges 18 years+ - NCT06444503Recruiting
A study collecting samples from children with bone problems
This study collects blood and tissue samples from children with bone or growth plate problems to build a research database. It aims to better understand these conditions and may help improve future treatments.
ToulouseAges Up to 99 years
Hear when a new Growth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for growth?
- Yes. Clin2 currently lists 295 recruiting growth studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a growth trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a growth trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.